JSAC(SH:600389)2015-10-26 16:00Financial Performance - Net profit attributable to shareholders decreased by 94.00% to CNY 11,326,073.07 for the first nine months of the year[6]. - Operating revenue for the first nine months decreased by 12.36% to CNY 2,032,929,897.56 compared to the same period last year[6]. - Total profit decreased by 94.36% to ¥14,079,791.81 compared to the same period last year, primarily due to a significant decline in gross profit from glyphosate products[15]. - The company expects a significant decline in net profit for the year compared to the previous year due to the current market conditions for major products like glyphosate[18]. - Net profit for Q3 2015 was a loss of ¥5,087,132.87, compared to a profit of ¥22,976,361.82 in Q3 2014[32]. - Net profit for the period was a loss of approximately ¥9.18 million, compared to a profit of ¥23.05 million in the same period last year, representing a decline of 139.8%[37]. - The total profit for the period was a loss of approximately ¥12.52 million, down from a profit of ¥30.56 million in Q3 2022[36]. Cash Flow and Liquidity - Net cash flow from operating activities decreased by 93.91% to CNY 14,616,780.33 for the first nine months[6]. - The company's cash and cash equivalents decreased by 47.62% to ¥103,624,646.68 compared to the beginning of the period, primarily due to reduced cash inflows from operating activities[11]. - Cash flow from operating activities generated a net amount of approximately ¥14.62 million, a significant decrease from ¥240.20 million in the same period last year[38]. - Total cash and cash equivalents at the end of the period stood at CNY 51,698,774.47, down from CNY 75,302,778.86 at the end of the same period last year[42]. - Cash received from sales of goods and services was CNY 1,579,435,487.62, down 27.7% from CNY 2,185,072,389.01 year-on-year[41]. - Cash paid for dividends and interest was CNY 93,594,675.55, down from CNY 141,391,628.51 in the previous year[42]. Assets and Liabilities - Total assets decreased by 9.98% to CNY 2,958,923,033.02 compared to the end of the previous year[6]. - The company's current assets totaled CNY 808,931,378.02, down from CNY 986,274,251.11 at the beginning of the year, indicating a decrease of about 17.93%[22]. - The total liabilities decreased from CNY 1,953,577,792.31 to CNY 1,675,557,859.53, a reduction of approximately 14.19%[24]. - The company's equity attributable to shareholders decreased from CNY 1,333,205,087.70 to CNY 1,283,365,173.49, reflecting a decline of about 3.74%[24]. - The inventory level decreased significantly from CNY 560,943,917.71 at the beginning of the year to CNY 445,267,298.55, representing a reduction of approximately 20.66%[22]. - Accounts receivable increased from CNY 182,019,067.36 to CNY 191,282,318.00, indicating an increase of about 5.93%[22]. Shareholder Information - The total number of shareholders reached 10,297 at the end of the reporting period[9]. - The largest shareholder, Sinochem International, holds 29.19% of the shares[9]. - The second largest shareholder, Nantong Industrial Holdings, holds 25.79% of the shares, with 25,530,000 shares pledged[9]. - The first and second largest shareholders have committed not to reduce their holdings for six months, and this commitment is still being honored as of the report date[17]. Expenses and Costs - Total operating costs for Q3 2015 were ¥482,405,812.52, down 22.6% from ¥622,738,233.61 in Q3 2014[31]. - Sales expenses increased to approximately ¥39.14 million, up from ¥36.44 million in the previous year, reflecting an increase of 7.4%[36]. - Management expenses decreased to approximately ¥106.99 million, down 24.7% from ¥141.93 million in the same period last year[36]. - Financial expenses rose to approximately ¥29.38 million, compared to ¥36.74 million in the previous year, indicating a decrease of 20.0%[36]. Investment and Income - The company's investment income decreased by 81.54% to ¥1,761,139.45, mainly due to a decline in profits from the joint venture Nantong Dongchang Chemical Co., Ltd.[15]. - Investment income showed a loss of approximately ¥1.38 million, contrasting with a profit of ¥1.22 million in Q3 2022[36].